Hematologic side effects in the 32 patients studied
Characteristics . | Value . |
|---|---|
| Median time to recovery for patients in CR* | |
| Platelet count at or above 100 × 109/L, d, mean (range) | 42 (22-62) |
| Neutrophil count at or above 1 × 109/L, d, mean (range) | 33 (18-59) |
| Febrile episodes, no. (%) | 20 (63) |
| Fever of unknown origin, no. (%) | 10 (31) |
| Documented infections, no. (%) | |
| Bacterial/sepsis | 14 (44) |
| Fungal | 3 (9) |
| Other/no identified source | 5 (16) |
Characteristics . | Value . |
|---|---|
| Median time to recovery for patients in CR* | |
| Platelet count at or above 100 × 109/L, d, mean (range) | 42 (22-62) |
| Neutrophil count at or above 1 × 109/L, d, mean (range) | 33 (18-59) |
| Febrile episodes, no. (%) | 20 (63) |
| Fever of unknown origin, no. (%) | 10 (31) |
| Documented infections, no. (%) | |
| Bacterial/sepsis | 14 (44) |
| Fungal | 3 (9) |
| Other/no identified source | 5 (16) |
n = 7.